Risk factors for post-ERCP pancreatitis: a prospective, multicenter study - PubMed (original) (raw)
Multicenter Study
doi: 10.1067/mge.2001.117550.
J A DiSario, D B Nelson, M B Fennerty, J G Lee, D J Bjorkman, C S Overby, J Aas, M E Ryan, G S Bochna, M J Shaw, H W Snady, R V Erickson, J P Moore, J P Roel
Affiliations
- PMID: 11577302
- DOI: 10.1067/mge.2001.117550
Multicenter Study
Risk factors for post-ERCP pancreatitis: a prospective, multicenter study
M L Freeman et al. Gastrointest Endosc. 2001 Oct.
Abstract
Background: Post-ERCP pancreatitis is poorly understood. The goal of this study was to comprehensively evaluate potential procedure- and patient-related risk factors for post-ERCP pancreatitis over a wide spectrum of centers.
Methods: Consecutive ERCP procedures were prospectively studied at 11 centers (6 private, 5 university). Complications were assessed at 30 days by using established consensus criteria.
Results: Pancreatitis occurred after 131 (6.7%) of 1963 consecutive ERCP procedures (mild 70, moderate 55, severe 6). By univariate analysis, 23 of 32 investigated variables were significant. Multivariate risk factors with adjusted odds ratios (OR) were prior ERCP-induced pancreatitis (OR 5.4), suspected sphincter of Oddi dysfunction (OR 2.6), female gender (OR 2.5), normal serum bilirubin (OR 1.9), absence of chronic pancreatitis (OR 1.9), biliary sphincter balloon dilation (OR 4.5), difficult cannulation (OR 3.4), pancreatic sphincterotomy (OR 3.1), and 1 or more injections of contrast into the pancreatic duct (OR 2.7). Small bile duct diameter, sphincter of Oddi manometry, biliary sphincterotomy, and lower ERCP case volume were not multivariate risk factors for pancreatitis, although endoscopists performing on average more than 2 ERCPs per week had significantly greater success at bile duct cannulation (96.5% versus 91.5%, p = 0.0001). Combinations of patient characteristics including female gender, normal serum bilirubin, recurrent abdominal pain, and previous post-ERCP pancreatitis placed patients at increasingly higher risk of pancreatitis, regardless of whether ERCP was diagnostic, manometric, or therapeutic.
Conclusions: Patient-related factors are as important as procedure-related factors in determining risk for post-ERCP pancreatitis. These data emphasize the importance of careful patient selection as well as choice of technique in the avoidance of post-ERCP pancreatitis.
Comment in
- ERCP is most dangerous for people who need it least.
Cotton PB. Cotton PB. Gastrointest Endosc. 2001 Oct;54(4):535-6. doi: 10.1067/mge.2001.118446. Gastrointest Endosc. 2001. PMID: 11577330 No abstract available. - Should we stop doing ERCP on patients with abdominal pain?
Hawes RH. Hawes RH. Rev Gastroenterol Disord. 2003 Winter;3(1):52-3. Rev Gastroenterol Disord. 2003. PMID: 12684595 No abstract available.
Similar articles
- Risk factors for post-ERCP pancreatitis: a prospective multicenter study.
Cheng CL, Sherman S, Watkins JL, Barnett J, Freeman M, Geenen J, Ryan M, Parker H, Frakes JT, Fogel EL, Silverman WB, Dua KS, Aliperti G, Yakshe P, Uzer M, Jones W, Goff J, Lazzell-Pannell L, Rashdan A, Temkit M, Lehman GA. Cheng CL, et al. Am J Gastroenterol. 2006 Jan;101(1):139-47. doi: 10.1111/j.1572-0241.2006.00380.x. Am J Gastroenterol. 2006. PMID: 16405547 Clinical Trial. - Risk factors for post-ERCP pancreatitis in high- and low-volume centers and among expert and non-expert operators: a prospective multicenter study.
Testoni PA, Mariani A, Giussani A, Vailati C, Masci E, Macarri G, Ghezzo L, Familiari L, Giardullo N, Mutignani M, Lombardi G, Talamini G, Spadaccini A, Briglia R, Piazzi L; SEIFRED Group. Testoni PA, et al. Am J Gastroenterol. 2010 Aug;105(8):1753-61. doi: 10.1038/ajg.2010.136. Epub 2010 Apr 6. Am J Gastroenterol. 2010. PMID: 20372116 - Risk factors for complications after performance of ERCP.
Vandervoort J, Soetikno RM, Tham TC, Wong RC, Ferrari AP Jr, Montes H, Roston AD, Slivka A, Lichtenstein DR, Ruymann FW, Van Dam J, Hughes M, Carr-Locke DL. Vandervoort J, et al. Gastrointest Endosc. 2002 Nov;56(5):652-6. doi: 10.1067/mge.2002.129086. Gastrointest Endosc. 2002. PMID: 12397271 - NIH state-of-the-science statement on endoscopic retrograde cholangiopancreatography (ERCP) for diagnosis and therapy.
[No authors listed] [No authors listed] NIH Consens State Sci Statements. 2002 Jan 14-16;19(1):1-26. NIH Consens State Sci Statements. 2002. PMID: 14768653 Review.
Cited by
- The Role of Magnesium in Acute Pancreatitis and Pancreatic Injury: A Systematic Review.
Pergolini I, Schorn S, Friess H, Demir IE. Pergolini I, et al. Visc Med. 2024 Oct;40(5):264-275. doi: 10.1159/000540507. Epub 2024 Sep 26. Visc Med. 2024. PMID: 39398394 - Efficacy of Diclofenac and Indomethacin for Prevention of Post-Endoscopic Cholangiopancreatography (ERCP) Pancreatitis: A Systematic Review.
Kotha R, Saad-Omer SI, Singh S, Olayinka OT, Orelus J, Nisar MR, Nassar ST. Kotha R, et al. Cureus. 2024 Aug 7;16(8):e66386. doi: 10.7759/cureus.66386. eCollection 2024 Aug. Cureus. 2024. PMID: 39246923 Free PMC article. Review. - Incidence of Post-ERCP Pancreatitis in Patients Receiving Rectal Indomethacin vs. Compounded Rectal Diclofenac Prophylaxis.
Janssens LP, Yamparala A, Martin J, O'Meara J, Harmsen WS, Sathi T, Lemke E, Abu Dayyeh BK, Bofill-Garcia A, Petersen BT, Storm AC, Topazian M, Vargas EJ, Chandrasekhara V, Law RJ. Janssens LP, et al. Dig Dis Sci. 2024 Oct;69(10):3970-3978. doi: 10.1007/s10620-024-08604-5. Epub 2024 Aug 31. Dig Dis Sci. 2024. PMID: 39215866 - The Impact of Intraoperative Glucagon on the Diagnostic Accuracy of Intraoperative Cholangiogram for the Diagnosis of Choledocholithiasis: Experience from a Large Tertiary Care Center.
Mittal N, Ali FS, Machado AP, Ngo S, Shatila M, DaVee T, Thosani N, Wadhwa V. Mittal N, et al. Diagnostics (Basel). 2024 Jul 1;14(13):1405. doi: 10.3390/diagnostics14131405. Diagnostics (Basel). 2024. PMID: 39001295 Free PMC article. - The Influence of Symptomatic Status on Post-endoscopic Retrograde Cholangiopancreatography (ERCP) Complications in Choledocholithiasis: A Systematic Review and Meta-Analysis.
Patel A, Vaghani UP, Mehta S, Avaiya PA, Virani M, Gorasiya F. Patel A, et al. Cureus. 2024 Apr 29;16(4):e59322. doi: 10.7759/cureus.59322. eCollection 2024 Apr. Cureus. 2024. PMID: 38817520 Free PMC article. Review.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical